Liberum Capital Reaffirms “Hold” Rating for Spire Healthcare Group PLC (SPI)
Liberum Capital reiterated their hold rating on shares of Spire Healthcare Group PLC (LON:SPI) in a report issued on Thursday morning. The firm currently has a GBX 270 ($3.55) target price on the stock.
Several other equities analysts have also recently issued reports on the stock. J P Morgan Chase & Co decreased their price target on shares of Spire Healthcare Group PLC from GBX 376 ($4.95) to GBX 339 ($4.46) and set a neutral rating for the company in a research report on Friday, September 15th. Numis Securities Ltd restated an add rating and issued a GBX 341 ($4.49) price target on shares of Spire Healthcare Group PLC in a research report on Monday, October 23rd. Credit Suisse Group restated an underperform rating on shares of Spire Healthcare Group PLC in a research report on Friday, July 21st. Berenberg Bank restated a hold rating and issued a GBX 270 ($3.55) price target on shares of Spire Healthcare Group PLC in a research report on Thursday, September 21st. Finally, Jefferies Group LLC decreased their price target on shares of Spire Healthcare Group PLC from GBX 350 ($4.60) to GBX 259 ($3.41) and set a hold rating for the company in a research report on Monday, September 25th. One equities research analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. The company presently has an average rating of Hold and an average target price of GBX 304.14 ($4.00).
Spire Healthcare Group PLC (SPI) opened at GBX 269.70 ($3.55) on Thursday. Spire Healthcare Group PLC has a 12-month low of GBX 218.20 ($2.87) and a 12-month high of GBX 371.10 ($4.88).
Spire Healthcare Group PLC (LON:SPI) last announced its quarterly earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). Spire Healthcare Group PLC had a net margin of 1.85% and a return on equity of 1.71%. The firm had revenue of £481 million during the quarter.
COPYRIGHT VIOLATION NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/11/19/liberum-capital-reaffirms-hold-rating-for-spire-healthcare-group-plc-spi.html.
The company also recently disclosed a dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Thursday, November 16th will be paid a GBX 1.30 ($0.02) dividend. This represents a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th.
In other news, insider Justin Ash acquired 89,100 shares of Spire Healthcare Group PLC stock in a transaction dated Friday, September 29th. The shares were bought at an average cost of GBX 224 ($2.95) per share, with a total value of £199,584 ($262,506.91).
Spire Healthcare Group PLC Company Profile
Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.
Receive News & Stock Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related stocks with our FREE daily email newsletter.